CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 3 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)»Certain disorders involving the immune mechanism (D80-D89)»Immunodeficiency with predominantly antibody defects (D80)

D80

Immunodeficiency with predominantly antibody defects

Sub-codes (10)

  • D80.0 Hereditary hypogammaglobulinemia
  • D80.1 Nonfamilial hypogammaglobulinemia
  • D80.2 Selective deficiency of immunoglobulin A [IgA]
  • D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses

    1 indication for 3 drugs

  • D80.4 Selective deficiency of immunoglobulin M [IgM]
  • D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
  • D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
  • D80.7 Transient hypogammaglobulinemia of infancy
  • D80.8 Other immunodeficiencies with predominantly antibody defects
  • D80.9 Immunodeficiency with predominantly antibody defects, unspecified

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.